Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results

European Journal of Surgical Oncology

Volumn 36, Issue 11, 2010, Pages 1054-1060

  Peng, Z W ^a,b   Zhang, Y J ^a,b   Chen, M S ^a,b   Lin, X J ^a,b   Liang, H H ^c   Shi, M ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

First line treatment; Hepatocellular carcinoma; Radiofrequency ablation; Survival

Indexed keywords

PROTHROMBIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; KAPLAN MEIER METHOD; LIVER FUNCTION TEST; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME; KAPLAN-MEIER ESTIMATE;

EID: 77957886570     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.08.133     Document Type: Article

References (30)

1. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
2. H.G. Welch, L.M. Schwartz, and S. Woloshin Are increasing 5-year survival rates evidence of success against cancer? JAMA 283 2000 2975 2978
3. F. Trevisani, N.S. De, and G.L. Rapaccini Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) Am J Gastroenterol 97 2002 734 744
4. F.Y. Yao, N.M. Bass, and B. Nikolai Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 2002 873 883
5. M. Schwartz Liver transplantation for hepatocellular carcinoma Gastroenterology 127 2004 S268 S276
6. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
7. E.C. Lai, S.T. Fan, C.M. Lo, K.M. Chu, C.L. Liu, and J. Wong Hepatic resection for hepatocellular carcinoma. An audit of 343 patients Ann Surg 221 1995 291 298
8. R. Lencioni, D. Cioni, and L. Crocetti Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967 (Pubitemid 40250844)
9. G. N'Kontchou, A. Mahamoudi, and M. Aout Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis Hepatology 50 2009 1475 1483
10. T. Livraghi, F. Meloni, and M. Di Stasi Sustained complete response and complications rate after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47 2008 82 89
11. M.S. Chen, J.Q. Li, and Y. Zheng A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321 328
12. W.Y. Lau, and E.C. Lai The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review Ann Surg 249 2009 20 25
13. W.Y. Lau, T.W. Leung, S.C. Yu, and S.K. Ho Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future Ann Surg 237 2003 171 179
14. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. European Association for the study of the liver J Hepatol 35 2001 421 430
15. M.H. Chen, W. Yang, and K. Yan Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients - mathematic model, overlapping mode, and electrode placement process Radiology 232 2004 260 271
16. Z.W. Peng, H.H. Liang, and M.S. Chen Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe Eur J Surg Oncol 34 2008 166 172
17. J. Hänsler, M. Frieser, and S. Schaber Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study J Vasc Interv Radiol 14 2003 575 580
18. J. Bruix, A. Castells, and J. Bosch Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure Gastroenterology 111 1996 1018 1022
19. T. Livraghi, S. Lazzaroni, F. Meloni, and L. Solbiati Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma Br J Surg 92 2005 856 858
20. S.N. Goldberg, P.F. Hahn, and K.K. Tanabe Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9 1998 101 111
21. D. Choi, H.K. Lim, and H. Rhim Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors Ann Surg Oncol 14 2007 2319 2329 (Pubitemid 47174899)
22. H.H. Liang, M.S. Chen, and Z.W. Peng Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study Ann Surg Oncol 15 2008 3484 3493
23. W. Yang, M.H. Chen, and S.S. Yin Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence AJR Am J Roentgenol 186 2006 S275 S283
24. D.S. Weng, J. Zhou, and Q.M. Zhou Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas J Immunother 31 2008 63 71
25. A. Veltri, P. Moretto, A. Doriguzzi, E. Pagano, G. Carrara, and G. Gandini Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) Eur Radiol 16 2006 661 669
26. Y.J. Zhang, H.H. Liang, and M.S. Chen Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial Radiology 244 2007 599 607
27. Z.W. Peng, M.S. Chen, and H.H. Liang A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma Eur J Surg Oncol 36 2010 257 263
28. D. Choi, H.K. Lim, and H. Rhim Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series Eur Radiol 17 2007 684 692
29. R. Tateishi, S. Shiina, and T. Teratani Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 2005 1201 1209 (Pubitemid 40328091)
30. X.D. Zhou, Z.Y. Tang, and B.H. Yang Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma Cancer 91 2001 1479 1486